Neurexis Therapeutics
Dr. Asfaha is a neuroscientist and biochemist with 9 years of experience investigating kinase signaling pathways underlying memory. She has published 13 peer-reviewed scientific papers and acquired 2 NIH National Research Service Awards (F31 and F32) as principal investigator.
Dr. Asfaha received her PhD in Pharmacology and Toxicology from the University of California, Davis. Now, in addition to her work with Neurexis, she studies CaMKII-dependent mechanisms as a Postdoctoral Fellow in the Department of Pharmacology at the University of Colorado, Anschutz Medical Campus.
This person is not in any teams
This person is not in any offices
Neurexis Therapeutics
Neurexis is developing an optimized peptide with demonstrated efficacy and safety in small and large animal models of global cerebral ischemia.